Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)

PHASE2CompletedINTERVENTIONAL
Enrollment

503

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
Coronary Artery Disease (CAD)
Interventions
DRUG

M118

intravenous (IV) infusion

DRUG

Unfractionated Heparin

IV infusion

Trial Locations (44)

15212

Allegheny Hospital, Pittsburgh

20010

Washington Hospital Center, Medstar Research Institute, Washington D.C.

22908

UVA Cardiology, UVA Health System, Charlottesville

23249

McGuire VA Medical Center, Richmond

27514

UNC Health Systems, Chapel Hill

30322

Emory University Hospital, Atlanta

32174

Cardiology Research Associates, Ormond Beach

32209

Shands Jacksonville Medical Center (UFL), Jacksonville

33308

Jim Moran Heart & Vascular Research Institute, Fort Lauderdale

33701

Suncoast Cardiovascular Research, St. Petersburg

37203

Centennial Heart Cardiovascular Consultants, Nashville

40536

University of Kentucky-Gill Heart Institute, Lexington

43214

Riverside Methodist Hospital, Columbus

43701

Genesis Health Care System, Zanesville

48202

Henry Ford Hospital Heart & Vascular Institute, Detroit

48439

Genesys Regional Medical Center, Grand Blanc

52803

Midwest Cardiovascular Research Foundation, Davenport

53215

Comprehensive Cardiology Care, Milwaukee

55417

Minneapolis VA Medical Center, Minneapolis

55805

Saint Mary's Duluth Clinic Health Center, Duluth

57701

Black Hills Clinical Research Center, Rapid City

60010

Advocate Good Shephard Hospital, Barrington

60612

Rush University Medical Center, Chicago

60637

University of Chicago, Chicago

61201

Trinity Medical Center, Rock Island

63110

Saint Louis University Hospital, St Louis

64111

Saint-Luke's Hospital / Mid America Heart Institute, Kansas City

72205

Central Arkansas Veterans Healthcare System, Little Rock

76104

Plaza Medical Center of Fort Worth, Fort Worth

76712

Providence Health Center, Waco

77030

The Methodist Hospital, Houston

77901

Victoria Heart & Vascular Center, Victoria

78756

Austin Heart, P.A., Austin

79106

Northwest Texas Healthcare System_Amarillo Heart Clinical Research Institute, Inc., Amarillo

02215

Beth Israel Deaconess Medical Center, Boston

48109-5869

University of Michigan Health System, Ann Arbor

27157-1045

Wake Forest University Health Sciences, Winston-Salem

T6G 2B7

University of Alberta Hospital, WMC, Edmonton

St. Michael's Hospital, Toronto

V5Z 1M9

Vancouver General Hospital: Interventional Research, Vancouver

K1Y 4WZ

University of Ottawa Heart Institute, Ottawa

M4N 3M5

Sunnybrook Health Sciences Center, Toronto

M5G 2C4

Toronto General Hospital, Toronto

H1T 1C8

Montreal Heart Institute, Montreal

Sponsors
All Listed Sponsors
lead

Momenta Pharmaceuticals, Inc.

INDUSTRY

NCT00543400 - Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) | Biotech Hunter | Biotech Hunter